Replimune to resubmit twice-rejected drug for approval after FDA shakeup

May 30, 2026 DG Health & Wellness News

In this article REPL Follow your favorite stocksCREATE FREE ACCOUNT Thomas Fuller | Lightrocket | Getty Images Replimune plans to resubmit its melanoma drug to

Tag: twice

Replimune to resubmit twice-rejected drug for approval after FDA shakeup

The Largest Undocumented Disparity in Maternal Health

Signos grows foothold in weight loss wave fueled by GLP-1s with its AI health data tracking

Healthy Returns: Eli Lilly makes a new push into vaccines — here’s what to know

The U.S. Is Proving the Case for the WHO

A 15-Minute Beginner Jump Rope Workout

How to Keep Your Musculoskeletal System Healthy

In Utah, Measles Sickens Babies and Others Who Can’t Be Vaccinated